Sanidad Animal
Fachbereich
Maria Auxiliadora
Dea Ayuela
Publikationen, an denen er mitarbeitet Maria Auxiliadora Dea Ayuela (13)
2013
-
Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations
International Journal of Pharmaceutics, Vol. 447, Núm. 1-2, pp. 38-46
2012
-
Multilocus genotyping of Giardia duodenalis in lambs from Spain reveals a high heterogeneity
Research in Veterinary Science, Vol. 93, Núm. 2, pp. 836-842
2011
-
MIND-BEST: Web server for drugs and target discovery; Design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from trichomonas gallinae
Journal of Proteome Research, Vol. 10, Núm. 4, pp. 1698-1718
-
NL MIND-BEST: A web server for ligands and proteins discovery-Theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum
Journal of Theoretical Biology, Vol. 276, Núm. 1, pp. 229-249
2009
-
Occurrence and genotypes of Giardia isolated from lambs in Spain
Parasitology International, Vol. 58, Núm. 3, pp. 297-299
2008
-
HPLC assay for determination of amphotericin B in biological samples
Biomedical Chromatography, Vol. 22, Núm. 4, pp. 402-407
2007
-
In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum
International Journal of Antimicrobial Agents, Vol. 30, Núm. 4, pp. 325-329
-
Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for In Vivo testing of antileishmanial compounds
Veterinary Research Communications, Vol. 31, Núm. 6, pp. 703-717
2006
-
Real-time reverse transcription-PCR quantification of cytokine mRNA expression in golden Syrian hamster infected with Leishmania infantum and treated with a new amphotericin B formulation
Antimicrobial Agents and Chemotherapy, Vol. 50, Núm. 4, pp. 1195-1201
2005
-
Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B
Journal of Drug Targeting, Vol. 13, Núm. 4, pp. 225-233
2004
-
Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis
Journal of Drug Targeting, Vol. 12, Núm. 7, pp. 453-460
-
Anti-leishmanial activity of a new formulation of amphotericin B
Tropical Medicine and International Health, Vol. 9, Núm. 9, pp. 981-990
-
Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres
Antimicrobial Agents and Chemotherapy, Vol. 48, Núm. 9, pp. 3246-3252